Rachael Pittala
Family · Windermere, FLNPI 1215440383
Payments from drug & device makers
Across 279 payments — averaging $27.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$908
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$870
- Teva Pharmaceuticals USA, Inc.$659
- Alkermes, Inc.$638
- Johnson & Johnson$575
- plus $2K from 14 others
What the payments were for
- Food & beverage$7,740100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 86 | $2,468 |
| Otsuka America Pharmaceutical, Inc. | 27 | $908 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $870 |
| Teva Pharmaceuticals USA, Inc. | 24 | $659 |
| Alkermes, Inc. | 23 | $638 |
| Johnson & Johnson | 23 | $575 |
| Corium, LLC | 3 | $258 |
| Neurocrine Biosciences, Inc. | 13 | $242 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $239 |
| Idorsia Pharmaceuticals US Inc | 9 | $221 |
| Supernus Pharmaceuticals, Inc. | 5 | $162 |
| Vanda Pharmaceuticals Inc. | 6 | $156 |
| Ironshore Pharmaceuticals Inc. | 6 | $107 |
| Lundbeck LLC | 4 | $86 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Sunovion Pharmaceuticals Inc. | 3 | $44 |
| Merck | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $13 |
| Genentech USA, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$937
- CAPLYTA$511
- LYBALVI$480
- ABILIFY MAINTENA$246
- Azstarys$242
- Austedo XR$220
- QELBREE$125
- ABILIFY ASIMTUFII$121
- REXULTI$116
- UZEDY$114
- INVEGA SUSTENNA$113
- INVEGA TRINZA$113
- QUVIVIQ$109
How this compares
$7,740 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 55 | $75,702 |
| RexultiBrexpiprazole | 18 | $29,159 |
| Aripiprazole | 19 | $1,691 |
| Duloxetine Hcl | 73 | $1,563 |
| Quetiapine Fumarate | 183 | $1,506 |
| Bupropion XlBupropion Hcl | 45 | $1,448 |
| Olanzapine | 18 | $1,387 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 13 | $571 |
| Buspirone Hcl | 71 | $554 |
| Mirtazapine | 56 | $538 |
| Trazodone Hcl | 75 | $480 |
| Escitalopram Oxalate | 80 | $364 |
| Ziprasidone Hcl | 16 | $357 |
| Prazosin Hcl | 42 | $245 |
| Risperidone | 27 | $244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $2,468 | $75,70255 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $908 | $29,15918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 14,618 family providers in Florida.
Other family in Windermere
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.